Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Cancer Prev Res (Phila). 2011 Jul 15;4(11):1799–1807. doi: 10.1158/1940-6207.CAPR-11-0107

Table 4.

Association between drug dose and duration of aspirin and non-aspirin NSAID and adenomatous polyp risk, the Tennessee Colorectal Polyp Study

Adenomatous Polyp
NSAID use Controls Cases OR* (95% CI)
Never 1654 748 1.00
Aspirin only use
 ≤ 7 doses a week
  < 5 years of use 400 174 0.73 (0.59, 0.91)
  ≥ 5 years of use 543 270 0.77 (0.64, 0.94)
 > 7 doses a week
  < 5 years of use 32 15 0.69 (0.36, 1.31)
  ≥ 5 years of use 78 51 0.92 (0.61, 1.36)
P-interaction 0.37
Single agent non-aspirin NSAID
 ≤ 7 doses a week
  < 5 years of use 84 27 0.62 (0.39, 0.99)
  ≥ 5 years of use 121 45 0.85 (0.59, 1.24)
 > 7 doses a week
  < 5 years of use 92 31 0.60 (0.38, 0.93)
  ≥ 5 years of use 123 43 0.58 (0.40, 0.86)
P-interaction 0.43
Any combination of NSAID
 ≤ 7 doses a week
  < 5 years of use 30 15 0.68 (0.35, 1.33)
  ≥ 5 years of use 93 50 0.89 (0.61, 1.30)
 > 7 doses a week
  < 5 years of use 27 7 0.42 (0.18, 0.99)
  ≥ 5 years of use 154 53 0.45 (0.32, 0.64)
P-interaction 0.83
*

Adjusted for age, gender, race, family history, education level, body mass index, energy intake, smoking status, alcohol use, physical activity, use of hormone replacement therapy, indication for colonoscopy, study site, and year of study enrollment.